一种可解释的深度学习方法用于使用基因表达数据诊断阿尔茨海默病
IEEE transactions on computational biology and bioinformatics
|August 14, 2025
概括
这项研究引入了一种新的可解释的深度学习方法,用于使用基因表达数据诊断阿尔茨海默病 (AD). 该方法实现了高精度 (95.13% AUROC),并为早期检测提供了生物学见解.
科学领域:
- 计算生物学是一种计算生物学.
- 神经科学是一个神经科学.
- 机器学习是机器学习.
背景情况:
- 全球人口老龄化增加了阿尔茨海默病 (AD) 的诊断紧迫性.
- 基因表达分析具有成本效益,但在AD诊断中面临着高维度挑战.
- 维度的诅咒阻碍了从基因表达数据中准确地诊断AD.
研究的目的:
- 开发一种新的,可解释的深度学习方法,用于准确的阿尔茨海默病诊断.
- 为了应对高维度和小样本大小在AD的基因表达数据中的挑战.
- 提高模型效率,并提供对AD机制的生物学见解.
主要方法:
- 使用浅浅的稀疏自动编码器来减少维度.
- 结合自动编码器与XGBoost分类器用于AD诊断.
- 开发了一个动态功能选择算法,以提高效率.
主要成果:
- 实现了95.13%的接收器操作特征曲线 (AUROC) 下的高面积.
- 在多个公共数据集 (ADNI,ANM1,ANM2) 中表现出强大的泛化性能.
- 通过丰富分析提供生物解释性,识别潜在的治疗点.
结论:
- 拟议的可解释深度学习方法对于早期和准确的阿尔茨海默病诊断是有效的.
- 该方法为临床应用提供了一个有前途的工具,克服了基因表达分析中的常见挑战.
- 从模型中获得的生物学见解可以促进对AD机制和治疗策略的理解.
相关概念视频
01:26Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
01:22Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261